Muhammad Tahseen
Overview
Explore the profile of Muhammad Tahseen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wahab A, Muqtadir J, Ansari A, Tahseen M, Ayoob K, Zaidi S, et al.
Cureus
. 2024 Dec;
16(11):e72972.
PMID: 39634970
Introduction Metabolic syndrome (MetS) encompasses a range of diverse conditions, such as hypertension, hyperglycemia, central obesity, dyslipidemia, and diabetes. MetS in non-diabetic elderly patients with acute ischemic stroke can worsen...
2.
Solangi A, Wahab A, Ansari A, Tahseen M, Zaidi S, Muqtadir J
Cureus
. 2024 Apr;
16(3):e56867.
PMID: 38659548
Introduction The most prevalent cause of death is acute myocardial infarction (AMI). Primary percutaneous coronary intervention (PPCI) has replaced thrombolysis as the recommended therapeutic option for individuals with ST-segment elevation...
3.
Asghar K, Bashir S, Rana I, Bakar M, Farooq A, Hassan M, et al.
J Hepatocell Carcinoma
. 2023 Jun;
10:921-934.
PMID: 37350801
Background/aim: Hepatocellular carcinoma (HCC) is one of the most common forms of liver cancer that is modulated by the immune system. Programmed cell death ligand-1 (PD-L1) has emerged as a...
4.
Asghar K, Rana I, Abubakar M, Hasham K, Tahseen M, Bilal S, et al.
Asian Pac J Cancer Prev
. 2023 May;
24(5):1591-1600.
PMID: 37247278
Background: Hepatocellular carcinoma (HCC) adopts several tumor immune escape mechanisms; therefore, it has the potential to be targeted by immunotherapy. Indoleamine 2, 3-dioxygenase (IDO) is an immunosuppressive enzyme that has...
5.
Saleem S, Aleem I, Zeshan M, Bakar M, Atiq A, Tahseen M, et al.
J Cancer Allied Spec
. 2023 May;
8(2):477.
PMID: 37197568
Introduction: Asian developing countries share the burden of colorectal cancer (CRC) with rising mortality rates. This prospective study aims to apprehend the clinical relevance of age, gender, lifestyle choices (dietary...
6.
Mahdi M, Ozer M, Tahseen M
Cureus
. 2021 Jul;
13(6):e15626.
PMID: 34277243
The critical state of circulatory collapse and hypoperfusion that results in end-organ damage has been called shock. Carcinoid crisis is a rare cause of shock, which is difficult to identify...
7.
Saleem S, Aleem I, Atiq A, Tariq S, Babar A, Bakar M, et al.
Ecancermedicalscience
. 2021 Apr;
15:1197.
PMID: 33889206
The aim of the study is to identify cornulin (CRNN) protein expression associated with advancement of tongue squamous cell carcinoma (TSCC). A comparison of addictive (containing potential carcinogens) versus non-addiction...
8.
Asghar K, Loya A, Rana I, Bakar M, Farooq A, Tahseen M, et al.
World J Clin Oncol
. 2021 Jan;
11(12):1018-1028.
PMID: 33437664
Background: Forkhead box P3 (FOXP3) is a specific marker for immunosuppressive regulatory T (T-reg) cells. T-regs and an immunosuppressive enzyme, indoleamine 2,3-dioxygenase (IDO), are associated with advanced disease in cancer....
9.
Saleem S, Tariq S, Aleem I, Sadr-Ul Shaheed , Tahseen M, Atiq A, et al.
Clin Proteomics
. 2020 Jan;
16:44.
PMID: 31889941
Background: The aim of this pilot study was to identify proteins associated with advancement of colon cancer (CC). Methods: A quantitative proteomics approach was used to determine the global changes...
10.
Asghar K, Loya A, Rana I, Bakar M, Farooq A, Tahseen M, et al.
Asian Pac J Cancer Prev
. 2019 Nov;
20(11):3521-3525.
PMID: 31759380
Background: Tumors use several immunosuppressive mechanisms to evade immune destruction. Cyclooxygenase-2 (COX-2) expression may be a driver of immunosuppression in breast cancer, but the mechanisms involved remain elusive. COX-2 expression...